AE Wealth Management LLC Sells 2,144 Shares of American Healthcare REIT, Inc. $AHR

AE Wealth Management LLC trimmed its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 10.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,212 shares of the company’s stock after selling 2,144 shares during the period. AE Wealth Management LLC’s holdings in American Healthcare REIT were worth $706,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of AHR. Physician Wealth Advisors Inc. purchased a new stake in American Healthcare REIT in the second quarter worth about $34,000. Avalon Trust Co bought a new position in shares of American Healthcare REIT during the 1st quarter valued at approximately $36,000. GAMMA Investing LLC increased its holdings in American Healthcare REIT by 22.1% in the 2nd quarter. GAMMA Investing LLC now owns 1,716 shares of the company’s stock worth $63,000 after acquiring an additional 311 shares in the last quarter. Meeder Asset Management Inc. bought a new stake in American Healthcare REIT during the 1st quarter worth approximately $97,000. Finally, Creekmur Asset Management LLC lifted its holdings in American Healthcare REIT by 86.8% during the first quarter. Creekmur Asset Management LLC now owns 3,882 shares of the company’s stock valued at $118,000 after purchasing an additional 1,804 shares in the last quarter. 16.68% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Mark E. Foster sold 3,850 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the transaction, the executive vice president directly owned 59,100 shares of the company’s stock, valued at approximately $2,475,699. This trade represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jeffrey T. Hanson sold 20,010 shares of the business’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $49.68, for a total transaction of $994,096.80. Following the completion of the sale, the director owned 21,798 shares in the company, valued at $1,082,924.64. This represents a 47.86% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 25,360 shares of company stock valued at $1,229,398 over the last quarter. Corporate insiders own 0.92% of the company’s stock.

American Healthcare REIT Price Performance

NYSE:AHR opened at $48.24 on Friday. The business’s 50-day moving average is $43.47 and its 200 day moving average is $39.28. American Healthcare REIT, Inc. has a 12 month low of $26.11 and a 12 month high of $50.51. The company has a market capitalization of $8.13 billion, a P/E ratio of 344.58, a P/E/G ratio of 2.36 and a beta of 0.98. The company has a current ratio of 0.44, a quick ratio of 0.48 and a debt-to-equity ratio of 0.37.

American Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, September 30th. American Healthcare REIT’s dividend payout ratio is 714.29%.

Analyst Ratings Changes

Several brokerages have recently commented on AHR. KeyCorp raised their price objective on shares of American Healthcare REIT from $43.00 to $55.00 and gave the company an “overweight” rating in a research report on Thursday. Truist Financial increased their price target on American Healthcare REIT from $44.00 to $46.00 and gave the stock a “buy” rating in a research note on Tuesday, August 26th. Royal Bank Of Canada boosted their price objective on American Healthcare REIT from $45.00 to $54.00 and gave the company an “outperform” rating in a research report on Wednesday. Zacks Research raised American Healthcare REIT from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 17th. Finally, Robert W. Baird assumed coverage on American Healthcare REIT in a research note on Friday, July 18th. They set an “outperform” rating and a $41.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, American Healthcare REIT currently has an average rating of “Buy” and a consensus price target of $49.40.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.